Cargando…
Curcumin derivative C212 inhibits Hsp90 and eliminates both growing and quiescent leukemia cells in deep dormancy
BACKGROUND: Relapsed leukemia following initial therapeutic response and remission is difficult to treat and causes high patient mortality. Leukemia relapse is due to residual quiescent leukemia cells that escape conventional therapies and later reemerge. Eliminating not only growing but quiescent l...
Autores principales: | Liu, Bi, Shen, Yunzhu, Huang, Huafang, Croce, Kimiko Della, Wu, Min, Fan, Yingjuan, Liu, Yang, Xu, Jianhua, Yao, Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523331/ https://www.ncbi.nlm.nih.gov/pubmed/32993709 http://dx.doi.org/10.1186/s12964-020-00652-4 |
Ejemplares similares
-
C0818, a novel curcumin derivative, interacts with Hsp90 and inhibits Hsp90 ATPase activity
por: Fan, Yingjuan, et al.
Publicado: (2017) -
Curcumin affects function of Hsp90 and drug efflux pump of Candida albicans
por: Lee, Yean Sheng, et al.
Publicado: (2022) -
Expression Patterns of the Heat Shock Protein 90 (Hsp90) Gene Suggest Its Possible Involvement in Maintaining the Dormancy of Dinoflagellate Resting Cysts
por: Deng, Yunyan, et al.
Publicado: (2021) -
Novel Hsp90 Inhibitor C086 Potently Inhibits Non-Small Cell Lung Cancer Cells As A Single Agent Or In Combination With Gefitinib
por: Wang, Liman, et al.
Publicado: (2019) -
Y‐632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo
por: Wang, Wenqian, et al.
Publicado: (2016)